Development of an enzyme-linked immunosorbent assay for the detection of human calretinin in plasma and serum of mesothelioma patients

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Raiko, Irina ^a   Sander, Ingrid ^a   Weber, Daniel G ^a   Raulf Heimsoth, Monika ^a   Gillissen, Adrian ^b   Kollmeier, Jens ^c   Scherpereel, Arnaud ^d   Brüning, Thomas ^a   Johnen, Georg ^a  

^a INSTITUT FÜR ARBEITSSCHUTZ DER DEUTSCHEN GESETZLICHEN UNFALLVERSICHERUNG IFA   (Germany)

^b Robert Koch Klinik   (Germany)

^c Respiratory Diseases Clinic Heckeshorn   (Germany)

^d UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; BIOTIN; CALCIUM; CALRETININ; POLYCLONAL ANTIBODY; RECOMBINANT CALRETININ; RECOMBINANT PROTEIN; STREPTAVIDIN; UNCLASSIFIED DRUG; ANTICOAGULANT AGENT; CALBINDIN; CALCIUM CHLORIDE; CHELATING AGENT; EDETIC ACID; HEPARIN; TUMOR MARKER;

ADULT; AGE; AGED; ANTIBODY DETECTION; ARTICLE; CANCER PATIENT; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FREEZE THAWING; GENDER; HUMAN; HUMAN TISSUE; IMMUNOASSAY; INTERMETHOD COMPARISON; MALE; MESOTHELIOMA; OCCUPATIONAL EXPOSURE; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN STABILITY; STORAGE TEMPERATURE; ANTIBODY SPECIFICITY; BLOOD; BUILDING MATERIAL; CHEMISTRY; COMPARATIVE STUDY; EVALUATION; LABORATORY DIAGNOSIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ANTIBODY SPECIFICITY; ANTICOAGULANTS; ASBESTOS; CALCIUM CHLORIDE; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CHELATING AGENTS; CONSTRUCTION MATERIALS; EDETIC ACID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPARIN; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PREDICTIVE VALUE OF TESTS; PROTEIN STABILITY; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; TUMOR MARKERS, BIOLOGICAL;

EID: 77952740219     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-242     Document Type: Article

References (25)

1. Greillier L, Baas P, Welch JJ, Hasan B, Passioukov A. Biomarkers for malignant pleural mesothelioma: current status. Mol Diagn Ther 2008, 12(6):375-390.
2. Scherpereel A, Lee YG. Biomarkers for mesothelioma. Curr Opin Pulm Med 2007, 13(4):339-443. 10.1097/MCP.0b013e32812144bb, 17534183.
3. Creaney J, Robinson BW. Serum and pleural fluid biomarkers for mesothelioma. Curr Opin Pulm Med 2009, 15(4):366-370. 10.1097/MCP.0b013e32832b98eb, 19417672.
4. Park EK, Sandrini A, Yates DH, Creaney J, Robinson BW, Thomas PS, Johnson AR. Soluble mesothelin-related protein in an asbestos-exposed population: the dust diseases board cohort study. Am J Respir Crit Care Med 2008, 178(8):832-837. 10.1164/rccm.200802-258OC, 18583574.
5. Weber DG, Johnen G, Taeger D, Weber A, Gross IM, Pesch B, Kraus T, Bruning T, Gube M. Assessment of Confounding Factors Affecting the Tumor Markers SMRP, CA125, and CYFRA21-1 in Serum. Biomark Insights 2010, 5:1-8. 2814766, 20130785.
6. Shiomi K, Hagiwara Y, Sonoue K, Segawa T, Miyashita K, Maeda M, Izumi H, Masuda K, Hirabayashi M, Moroboshi T, et al. Sensitive and specific new enzyme-linked immunosorbent assay for N-ERC/mesothelin increases its potential as a useful serum tumor marker for mesothelioma. Clin Cancer Res 2008, 14(5):1431-1437. 10.1158/1078-0432.CCR-07-1613, 18316566.
7. Porcel JM, Vives M, Esquerda A, Salud A, Perez B, Rodriguez-Panadero F. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. Chest 2004, 126(6):1757-1763. 10.1378/chest.126.6.1757, 15596670.
8. Rogers JH. Calretinin: a gene for a novel calcium-binding protein expressed principally in neurons. J Cell Biol 1987, 105(3):1343-1353. 10.1083/jcb.105.3.1343, 2114790, 3654755.
9. Schwaller B, Meyer M, Schiffmann S. 'New' functions for 'old' proteins: the role of the calcium-binding proteins calbindin D-28k, calretinin and parvalbumin, in cerebellar physiology. Studies with knockout mice. Cerebellum 2002, 1(4):241-258. 10.1080/147342202320883551, 12879963.
10. Gander JC, Gotzos V, Fellay B, Schwaller B. Inhibition of the proliferative cycle and apoptotic events in WiDr cells after down-regulation of the calcium-binding protein calretinin using antisense oligodeoxynucleotides. Exp Cell Res 1996, 225(2):399-410. 10.1006/excr.1996.0191, 8660929.
11. Henzi T, Blum WV, Pfefferli M, Kawecki TJ, Salicio V, Schwaller B. SV40-induced expression of calretinin protects mesothelial cells from asbestos cytotoxicity and may be a key factor contributing to mesothelioma pathogenesis. Am J Pathol 2009, 174(6):2324-2336. 10.2353/ajpath.2009.080352, 2684196, 19435792.
12. Gotzos V, Vogt P, Celio MR. The calcium binding protein calretinin is a selective marker for malignant pleural mesotheliomas of the epithelial type. Pathol Res Pract 1996, 192(2):137-147.
13. Doglioni C, Tos AP, Laurino L, Iuzzolino P, Chiarelli C, Celio MR, Viale G. Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol 1996, 20(9):1037-1046. 10.1097/00000478-199609000-00001, 8764740.
14. King JE, Thatcher N, Pickering CA, Hasleton PS. Sensitivity and specificity of immunohistochemical markers used in the diagnosis of epithelioid mesothelioma: a detailed systematic analysis using published data. Histopathology 2006, 48(3):223-232. 10.1111/j.1365-2559.2005.02331.x, 16430468.
15. Schwaller B, Celio MR, Doglioni C. Identification of calretinin and the alternatively spliced form calretinin-22k in primary pleural mesotheliomas and in their metastases. Anticancer Res 2004, 24(6):4003-4009.
16. Comin CE, Saieva C, Messerini L. h-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary. Am J Surg Pathol 2007, 31(8):1139-1148. 10.1097/PAS.0b013e318033e7a8, 17667535.
17. Ordonez NG. What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? A review and update. Hum Pathol 2007, 38(1):1-16. 10.1016/j.humpath.2006.08.010, 17056092.
18. Schierle GS, Gander JC, D'Orlando C, Ceilo MR, Vogt Weisenhorn DM. Calretinin-immunoreactivity during postnatal development of the rat isocortex: a qualitative and quantitative study. Cereb Cortex 1997, 7(2):130-142. 10.1093/cercor/7.2.130, 9087821.
19. Schwaller B, Meyer-Monard S, Gander JC, Pugin P, Celio MR, Ludwig C. The calcium-binding protein calretinin-22k is detectable in the serum and specific cells of cancer patients. Anticancer Res 1998, 18(5B):3661-3667.
20. Winsky L, Kuznicki J. Antibody recognition of calcium-binding proteins depends on their calcium-binding status. J Neurochem 1996, 66(2):764-771.
21. Zimmermann L, Schwaller B. Monoclonal antibodies recognizing epitopes of calretinins: dependence on Ca2+-binding status and differences in antigen accessibility in colon cancer cells. Cell Calcium 2002, 31(1):13-25. 10.1054/ceca.2001.0255, 11990296.
22. Schwaller B, Durussel I, Jermann D, Herrmann B, Cox JA. Comparison of the Ca2+-binding properties of human recombinant calretinin-22k and calretinin. J Biol Chem 1997, 272(47):29663-29671. 10.1074/jbc.272.47.29663, 9368033.
23. Wiethege T. Differentialdiagnose bösartiger Pleuratumoren - Immunhistochemische und molekularbiologische Untersuchungsbefunde. PhD Thesis 2000, University Essen.
24. Larsen A, Bronstein IB, Dahl O, Wentzel-Larsen T, Kristoffersen EK, Fagerhol MK. Quantification of S100A12 (EN-RAGE) in blood varies with sampling method, calcium and heparin. Scand J Immunol 2007, 65(2):192-201. 10.1111/j.1365-3083.2006.01875.x, 17257225.
25. Weber DG, Taeger D, Pesch B, Kraus T, Bruning T, Johnen G. Soluble mesothelin-related peptides (SMRP) - High stability of a potential tumor marker for mesothelioma. Cancer Biomark 2007, 3(6):287-292.